NCT00032292 - Research Study of Visilizumab for Treatment of Acute Graft Versus Host Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions

Graft vs Host Disease

Interventions

DRUG

Visilizumab

Trial Locations (7)

Duke University, Durham

Washington University School of Medicine, St Louis

MD Anderson Cancer Center, Houston

City of Hope National Medical Center, Duarte

Fred Hutchinson Cancer Research Center, Seattle

Stanford University Medical Center, Stanford

Vanderbilt University Medical Center, Nashville